1. 2017
  2. Rational Design of Nanobody80 Loop Peptidomimetics: Towards Biased β 2 Adrenergic Receptor Ligands

    Martin, C., Moors, S. L. C., Danielsen, M., Betti, C., Fabris, C., Pedersen, D. S., Pardon, E., Peyressatre, M., Feher, K., Martins, J. C., Mathiesen, J. M., Morris, M. C., Devoogdt, N., Caveliers, V., De Proft, F., Steyaert, J. & Ballet, S., 18 Jul 2017, In : Chemistry - a European Journal. 23, 40, p. 9632-9640 9 p.

    Research output: Contribution to journalArticle

  3. Astatinated nanobodies, a promising new approach in targeted alpha therapy. A preclinical study

    Dekempeneer, Y., D'Huyvetter, M., Aneheim, E., Xavier, C., Lahoutte, T., Bäck, T., Jensen, H., Caveliers, V. & Lindgren, S., 16 May 2017.

    Research output: Unpublished contribution to conferencePoster

  4. 213Bismuth-labeled nanobodies, a promising new treatment approach in Targeted Alpha Therapy

    Dekempeneer, Y., Maertens, D., Gysemans, M., Lahoutte, T., D'Huyvetter, M., Cardinaels, T. & Caveliers, V., 11 May 2017.

    Research output: Unpublished contribution to conferencePoster

  5. Al 18F-labeling of heat-sensitive biomolecules for positron emission tomography imaging

    Cleeren, F., Lecina, J., Ahamed, M., Raes, G., Devoogdt, N., Caveliers, V., McQuade, P., Rubins, D. J., Li, W., Verbruggen, A., Xavier, C. & Bormans, G., 2017, In : Theranostics. 7, 11, p. 2924-2939 16 p.

    Research output: Contribution to journalArticle

  6. Development of potent and receptor subtype selective neuromedin U analogs

    De Prins, A., Martin, C., Van Wanseele, Y., Tömböly, C., Tourwe, D., Caveliers, V., Van Eeckhaut, A., Holst, B., Rosenkilde, M. M., Smolders, I. & Ballet, S., 2017, (Unpublished).

    Research output: Unpublished contribution to conferencePoster

Previous 1 2 3 4 5 6 7 8 ...21 Next

ID: 157891